Different inhibitors were used to block or limit the activity of PKM2, such as treatment with a glycolysis inhibitor, 2-DG or (R,R’)-4′-methoxy-1-naphthylfenoterol, in both cases reductions in tumor proliferation, cancer cell survival and invasion were observed [102,190]. Here, PKM is linked to neoplasm.